CanadaApotex Inc. Extra Strength Ibuprofen Liquid Gel Capsules 400 mg (DIN 02376601) in lots 1570619, 1570621 and 1570623 are affected and can be identified by cloudy capsules. They were recalled because ibuprofen has crystallized into the gelatin shell, causing the cloudiness. Verify if your product is from the affected lots, consult your healthcare provider before stopping use, contact Apotex with questions, and report any side effects or safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: Apotex Inc., 150 Signet Drive, Toronto Ontario, M9L 1T9.
How to identify it
Brand: Apotex Inc.; Product Name: Extra Strength Ibuprofen Liquid Gel Capsules; Market Authorization: DIN 02376601; Dosage Form: Capsules; Strength: Ibuprofen 400mg; Lot: 1570619, 1570621, 1570623
The hazard
Presence of cloudy capsules in affected lots due to crystallization of ibuprofen into the gelatin shell.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)